Cardiac Index-Guided Intraoperative Hemodynamic Management in Pediatric Moyamoya Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-18
SponsorSeoul National University Hospital

About this trial

This prospective randomized controlled trial evaluates whether individualized cardiac index-guided intraoperative hemodynamic management reduces postoperative transient ischemic episodes in pediatric patients undergoing encephaloduroarteriosynangiosis (EDAS) for Moyamoya disease. Patients are randomized 1:1 to goal-directed fluid therapy based on baseline cardiac index versus standard arterial pressure-based management. The primary outcome is the incidence of transient ischemic episodes during hospitalization.

Eligibility criteria

Qualifiers

Pediatric patients <18 years undergoing EDAS for Moyamoya disease under general anesthesia

Disqualifiers

ASA physical status 4-5

Emergency surgery

Known cardiovascular disease

Any condition judged inappropriate by investigators

Trial design

Treatments tested in this trial

  • Cardiac Index-Guided Hemodynamic Management
  • Blood Pressure-Guided Standard Hemodynamic Management

Treatment groups

94 Participants
are divided into 2 treatment groups